logo
Real Time Medical Systems Launches New Value-Based Care Solution, Delivering Live Post-Acute Care Insights

Real Time Medical Systems Launches New Value-Based Care Solution, Delivering Live Post-Acute Care Insights

Business Wire2 days ago

BALTIMORE--(BUSINESS WIRE)-- Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, and HITRUST Certified interventional analytics solution, announces the launch of its latest solution aimed at improving care and reducing costs: the Value-Based Care Dashboard. Designed to support better outcomes and enhanced coordination with post-acute care partners, the tool offers providers and health plans a centralized, real-time view of key quality and performance metrics – enabling organizations to thrive in value-based care models.
The Value-Based Care Dashboard is more than a reporting tool – it's a strategic asset. It centralizes insights, eliminates fragmented workflows, and empowers providers to make timely, informed decisions in collaboration with their post-acute partners.
Share
The Value-Based Care Dashboard consolidates critical enterprise-level actionable insights into a single, intuitive screen. Featuring six interactive Cards, it provides visibility into readmissions, risk stratification, quality measures, and hospital utilization trends during the patient's post-acute stay. With a streamlined interface, users can quickly access key clinical information they need – without navigating to multiple systems.
Key Features Include:
Short Stay Quality Measures: Track CMS-defined measures using live clinical documentation
Long Stay Quality Measures: Monitor long-term outcomes with national and state benchmarks
Average Admissions per 1000 Members: Measure all-cause hospital admissions
Readmission Risk Distribution: Categorize patients by readmission risk using Real Time's proprietary CARD score
Average Readmission Rates: View 30-day readmission percentages by month of admission
Monthly Admissions per 1000 Members: Analyze hospital admissions across the enterprise on a monthly basis
'Driven by ongoing feedback from our partners, we're committed to evolving Real Time's solution to meet the dynamic needs of value-based care,' said Tim Buono, Chief Strategy & Development Officer at Real Time. 'The Value-Based Care Dashboard is more than a reporting tool – it's a strategic asset. It centralizes essential insights, eliminates fragmented workflows, and empowers providers to make timely, informed decisions in collaboration with their post-acute partners.'
The dashboard is especially valuable for acute care and health plan providers seeking greater visibility into patients' post-acute journeys. By integrating critical clinical data – such as readmission rates, risk levels, and quality measures – into one dashboard, Real Time helps organizations strengthen collaboration and alignment across the care continuum.
With this launch, Real Time reinforces its role as a trusted partner in advancing care coordination – delivering tools that lead with precision, insight, and measurable impact in a value-based future.
About Real Time Medical Systems
Real Time Medical Systems is the industry-leading, KLAS Rated, and HITRUST Certified Interventional Analytics solution that turns post-acute EHR data into actionable insights. Serving healthcare organizations nationwide, Real Time improves value-based care outcomes by reducing hospital readmissions/admissions, accurately managing reimbursements, detecting early signs of infectious disease, automating antibiotic surveillance, and advancing care coordination through post-acute data transparency.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cowabunga Bay employee exposed to chemicals, prompting hazmat response
Cowabunga Bay employee exposed to chemicals, prompting hazmat response

Yahoo

time3 hours ago

  • Yahoo

Cowabunga Bay employee exposed to chemicals, prompting hazmat response

LAS VEGAS (KLAS) — An employee at a local waterpark was reportedly exposed to chemicals Friday morning, prompting a hazmat response and delayed opening of the park. The incident happened at Cowabunga Bay, which is located in the 900 block of West Galleria Drive near Gibson Road. Cowabunga Bay said the incident involved the handling of pool-related chemicals. When the incident occurred, the waterpark was closed to the public and the facility delayed the opening while the incident was resolved. The Henderson Fire Department said the employee was taken to a nearby hospital in stable condition. HFD's Hazardous Materials Team stayed on site for a short time to ensure the area was safe before operations resumed. As of 12:40 p.m., Cowabunga Bay was fully opened and announced that the planned 21+ event for Friday evening would proceed as planned. 'The safety and well-being of our team members and guests is our top priority,' a representative of the waterpark said in a statement. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Bruker Corporation to Present at the Jefferies Global Healthcare Conference
Bruker Corporation to Present at the Jefferies Global Healthcare Conference

Yahoo

time4 hours ago

  • Yahoo

Bruker Corporation to Present at the Jefferies Global Healthcare Conference

BILLERICA, Mass., May 30, 2025--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4th, 2025 at 5:30 PM Eastern Time. A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at A replay of the presentation will be posted in the "Events & Presentations" section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation. About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit View source version on Contacts Joe KostkaDirector, Investor RelationsBruker CorporationT: +1 (978) 313-5800E: Sign in to access your portfolio

Bruker Corporation to Present at the Jefferies Global Healthcare Conference
Bruker Corporation to Present at the Jefferies Global Healthcare Conference

Business Wire

time4 hours ago

  • Business Wire

Bruker Corporation to Present at the Jefferies Global Healthcare Conference

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4 th, 2025 at 5:30 PM Eastern Time. A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at A replay of the presentation will be posted in the 'Events & Presentations' section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation. About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store